Product Name: Human CD7 Antibody (GrisnilimAb, Research Use)
Catalog Number: NBR-0590
Target Name: CD7
Trade Name: GrisnilimAb
Antibody Drug Description: Grisnilimab (WT1), a IgG2a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD7
Synonyms: GP40; TP41; CD7 Molecule
Target Description: CD7 (CD7 Molecule) is a Protein Coding gene. Diseases associated with CD7 include Mycosis Fungoides and Lymphoblastic Lymphoma. Among its related pathways are Innate Lymphoid Cells Differentiation. Gene Ontology (GO) annotations related to this gene include signaling receptor activity.
Ensembl: ENSG00000173762
Uniprot: P09564